SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-041415
Filing Date
2011-07-20
Accepted
2011-07-20 17:03:07
Documents
3
Period of Report
2011-07-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v229232_8k.htm 8-K 20359
2 v229232_ex99-1.htm EX-99.1 9983
3 GRAPHIC logo.jpg GRAPHIC 26775
  Complete submission text file 0001144204-11-041415.txt   68703
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 11978090
SIC: 4731 Arrangement of Transportation of Freight & Cargo